Clinical Trials Directory

Trials / Unknown

UnknownNCT06022575

Telehealth Integrated Care Model in Patients With Cardiometabolic Disease

Evaluation of the Telehealth Integrated Care Model in Patients With Hyperlipidemia and Other Cardiometabolic Disease

Status
Unknown
Phase
Study type
Observational
Enrollment
1,302 (estimated)
Sponsor
Peking University Third Hospital · Academic / Other
Sex
All
Age
16 Years – 85 Years
Healthy volunteers

Summary

The objective of this study is to evaluate the telehealth integrated care model for its clinical efficacy, medical resource utilization, health economics measurement, and satisfaction survey indicators in hyperlipidemia patients and other cardiometabolic diseases. The result of the study will provide evidence for the value of integrated model in the treatment of patients with cardiometabolic syndrome.

Detailed description

Efficacy evaluation is critical for understanding the practical application effect of telehealth integrated mode in the therapy of cardiometabolic disease patients. We can comprehend the influence of the combination of online and offline models on patients' clinical curative effect, medication compliance, medical cost, and satisfaction by analyzing the curative effect and finding a scientific basis for clinical practice and policy formation. As a result, the purpose of this study is to assess the curative effect of hyperlipidemia patients with other cardiometabolic disease using a telehealth integrated model, as well as to investigate the potential benefits and risks of this model in the management of cardiometabolic disease.

Conditions

Interventions

TypeNameDescription
PROCEDURETelehealth integrated careFollowed up in online Internet hospital, estimated and adjusted treatment accroding to clinical efficacy, and send individualized health education messages regularly.
PROCEDUREConventional health careFollowed up face-to-face in cardiacmetabolic clinics, estimated and adjusted treatment accroding to clinical efficacy, and conducted health education.

Timeline

Start date
2023-06-20
Primary completion
2024-06-20
Completion
2025-07-20
First posted
2023-09-05
Last updated
2023-09-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06022575. Inclusion in this directory is not an endorsement.